3186 results for «7929»

Filter By

3186 results

Therapeutic choices for TTVIV-TTVIR interventions

21 May 2025 – From EuroPCR 2025

Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.

Therapeutic choices for TTVIV-TTVIR interventions

Percutaneous treatment in congenital heart disease

19 May 2022 – From EuroPCR 2022

This session will enable you to discover the different percutaneous procedures when addressing congenital heart disease, including MitraClip when correcting tricuspid regurgitation, alternative modified transsubclavian access for interventional thrombus suction and pulmonary valve among others!

Percutaneous treatment in congenital heart disease

Multiple VHD: a diagnostic and clinical challenge

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.

Multiple VHD: a diagnostic and clinical challenge

Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)

18 May 2023 – From EuroPCR 2023

Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.

Knocking mitral regurgitation

Long-term valve performance for the next decade and beyond

17 May 2023 – From EuroPCR 2023

How can TAVI outcomes be made better for younger patients with longer life horizons? Check-out in this session where you also will be able to gain in the understanding of the structural challenges of providing TAVI services and see how innovation can contribute to optimal outcomes and...

Long-term valve performance

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

An intrepid solution for transfemoral treatment of mitral regurgitation

21 Nov 2023 – From PCR London Valves 2023

In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.

An intrepid solution for transfemoral treatment of mitral regurgitation

Mitral valve disease: diagnosis and treatment selection

23 Nov 2021 – From PCR London Valves 2021

In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.

Mitral valve disease: diagnosis and treatment selection

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

25 Nov 2024 – From PCR London Valves 2024

Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

Innovations in TMVR and Intrepid trial updates

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...

Innovations in TMVR and Intrepid trial updates

Create the future of TAVI - Optimisation of the procedure and patient pathway

27 Nov 2022 – From PCR London Valves 2022

Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...

Create the future of

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Predicting and managing TAVI conduction related disorders

20 May 2022 – From EuroPCR 2022

Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.

Predicting and managing TAVI conduction related disorders

Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...

19 Nov 2023 – From PCR London Valves 2023

Discover the mitral late-breaking trials which were presented during PCR London Valves 2023: 

  • One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
  • AltaValve transseptal programme update
  • Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
  • Combined impact of mitral valve gradients and mitral regurgitation reduction...
Mitral Late-Breaking Trials - PCR London Valves 2023

TAVI essentials: anatomical factors, prosthesis selection, and complication management

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...

TAVI essentials: anatomical factors, prosthesis selection, and complication management

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Addressing the complex diagnostic challenges in aortic stenosis and regurgitation, this session examines the timing of treatment initiation and the decision-making process when aortic valve disease coincides with aortic pathology. It also explores the ongoing healthcare burden posed by mitral regurgitation and stenosis, emphasizing the importance...

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

Tricuspid hotline: new devices

22 May 2025 – From EuroPCR 2025

Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.

Tricuspid hotline: new devices

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

TriClip therapy: here now, here to stay

19 May 2022 – From EuroPCR 2022

Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.

TriClip therapy: here
Didn’t find what you were looking for?